Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating activities
Net loss	$ (1,246,887)	$ (1,647,205)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	106,584	300,000
Shares issued for settlement	62,000
Shares issued for financing costs		135,813
Warrants issued for financing costs		360,906
Depreciation and amortization	2,566	5,100
Amortization of debt discount	423,399	26,330
Change in fair value of derivative liability		(427,709)
Gain from settlement of liabilities		(114,478)
Gain from settlement of derivative liabilities
Gain on disposition of assets
Impairment expense	5,247	27,913
Financing costs		147
Default penalty
Changes in operating assets and liabilities:
Accounts receivable	141,082	(33,459)
Inventory	42,132	(6,394)
Prepaid expenses	15,000	15,952
Accounts payable	(3,868)	157,262
Customer deposit		(21,523)
Accrued expenses		(26,760)
Accrued interest	80,000	218,192
Accrued interest, related party
Payroll and taxes payable, primarily related party	13,956	84,002
Net cash used in operating activities	(358,789)	(945,911)
Investing activities:
Net cash used in investing activities
Financing activities:
Proceeds from convertible notes payable		999,853
Proceeds from notes payable		116,980
Repayment of note payable	(731)
Net cash (used in) provided by financing activities	(731)	1,116,833
Net increase in cash	(359,520)	170,922
Cash, beginning of period	365,162	20,867
Cash, end of period	5,642	191,789
Cash paid for income taxes
Cash paid for interest	202,994	24,062
Supplemental schedule of non-cash investing and financing activities:
Debt discount at origination		$ 111,111